
6.62 Delayed Data As of 3:59pm ET | ![]() Today’s Change | 1.77 Today|||52-Week Range 9.22 | +140.73% Year-to-Date |
The 5 analysts offering 12-month price forecasts for Verrica Pharmaceuticals Inc have a median target of 11.00, with a high estimate of 15.00 and a low estimate of 10.00. The median estimate represents a +66.16% increase from the last price of 6.62.
The current consensus among 6 polled investment analysts is to Buy stock in Verrica Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.